{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:03:26Z","timestamp":1790996606636,"version":"4.1.0"},"reference-count":50,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Critical Path for Parkinson's","award":["$2,000.00"],"award-info":[{"award-number":["$2,000.00"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>People with Parkinson's disease (PD) are prescribed a variety of medications to mitigate symptoms and improve their quality of life. These symptomatic therapies cover a range of pharmacological classes, including classical dopaminergic treatments, other antiparkinsonian agents, and pharmacotherapies for non-PD conditions. Often, medications are prescribed for concomitant use and in increasing doses, particularly as the disease progresses. Documentation of these interventions in clinical trials is necessary to accurately capture medication usage, compare medication utilization across different studies, understand factors contributing to experimental therapeutic response, and analyze clinical trial data in a precise manner. At the present time, there is no current international standard for how these medications are documented within clinical trials. As a case example, we will highlight medication use documentation in a large international multicenter observational study commonly used as a reference for design of clinical trials. This review aims to raise awareness within the scientific community of the importance of proper medication documentation and the need for standardization to harmonize prescriptive practices, improve treatment interpretability, and perform consistently robust analyses from clinical trials data.<\/jats:p>","DOI":"10.1177\/1877718x241305711","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T21:33:59Z","timestamp":1736890439000},"page":"227-235","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Addressing the need for standardization of symptomatic medication documentation in Parkinson's disease clinical research: A call to action"],"prefix":"10.1177","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0482-8925","authenticated-orcid":false,"given":"Mikayla","family":"Spott","sequence":"first","affiliation":[{"name":"Critical Path for Parkinson's Consortium, Critical Path Institute, Tucson, AZ, USA"},{"name":"Drexel University College of Medicine, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3787-8672","authenticated-orcid":false,"given":"Monica","family":"Javidnia","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Rochester, Rochester, NY, USA"},{"name":"Center for Health + Technology, University of Rochester, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pedata","sequence":"additional","affiliation":[{"name":"Critical Path for Parkinson's Consortium, Critical Path Institute, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1133-7202","authenticated-orcid":false,"given":"Martijn","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Critical Path for Parkinson's Consortium, Critical Path Institute, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7359-4670","authenticated-orcid":false,"given":"Laura","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Critical Path for Parkinson's Consortium, Critical Path Institute, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Simuni","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Pagano","sequence":"additional","affiliation":[{"name":"University of Exeter Medical School, London, UK"},{"name":"F. Hoffman-La Roche, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7691-9143","authenticated-orcid":false,"given":"Kevin","family":"Kwok","sequence":"additional","affiliation":[{"name":"Parkinson's Patient Activist, Boulder, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Romero","sequence":"additional","affiliation":[{"name":"Critical Path for Parkinson's Consortium, Critical Path Institute, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Stephenson","sequence":"additional","affiliation":[{"name":"Critical Path for Parkinson's Consortium, Critical Path Institute, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14077"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0478-0"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-150646"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0031"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-1305-0"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202867"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203395"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0127-1"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.06.026"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.02.001"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197601050-00001"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890180203"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.2001.0819"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12646"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29410"},{"key":"e_1_3_4_18_2","article-title":"GLP-1 receptor agonists for Parkinson's disease","volume":"7","author":"Mulvaney CA","year":"2020","unstructured":"Mulvaney CA, Duarte GS, Handley J, et al. GLP-1 receptor agonists for Parkinson's disease. Cochrane Database Syst Rev 2020; 7: CD012990.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2020.104283"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-171100"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27845"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.553635"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.644"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30328-9"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316213"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1634"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23829"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88619-4"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-201973"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0065-1"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00109-6"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2016-0370"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-150570"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/1740774516653238"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.816465"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2019.6867"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1111260"},{"key":"e_1_3_4_38_2","first-page":"65","article-title":"Implementing digital technologies in clinical trials: lessons learned","volume":"19","author":"Mitsi G","year":"2022","unstructured":"Mitsi G, Grinnell T, Giordano S, et al. Implementing digital technologies in clinical trials: lessons learned. Innov Clin Neurosci 2022; 19: 65\u201369.","journal-title":"Innov Clin Neurosci"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00080-6"},{"key":"e_1_3_4_40_2","article-title":"Digital health technology to measure drug efficacy in clinical trials for Parkinson\u2019s disease: a regulatory perspective","volume":"11","author":"Sacks L","year":"2021","unstructured":"Sacks L, Kunkoski E. Digital health technology to measure drug efficacy in clinical trials for Parkinson\u2019s disease: a regulatory perspective. J Parkinsons Dis 2021; 11: S111\u2013S115.","journal-title":"J Parkinsons Dis"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13533"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05751-0"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.02.011"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.04.018"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00533-w"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2017.03.006"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12845"},{"key":"e_1_3_4_48_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/d41573-023-00041-9","article-title":"FDA Approves first Friedreich\u2019s ataxia drug","volume":"22","author":"Mullard A","year":"2023","unstructured":"Mullard A. FDA Approves first Friedreich\u2019s ataxia drug. Nat Rev Drug Discov 2023; 22: 258\u2013258.","journal-title":"Nat Rev Drug Discov"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-239901"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-225111"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-219006"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241305711","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X241305711","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241305711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:50:58Z","timestamp":1777589458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X241305711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1177\/1877718X241305711"],"URL":"https:\/\/doi.org\/10.1177\/1877718x241305711","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]}}}